Beta© 2026 Adaptrex, LLC
Beta© 2026 Adaptrex, LLC
Federal grant · project grant (b)
Objective of This Project Is to Develop a Diagnostic Assay for Rapid Detection of Avian Metapneumovirus (AMPV) in Less Than 30 Minutes Using a Novel Multiplex Molecular Diagnostic Assay.this Diagnostic Assay Will Be Based on a Multiplex Loop-mediated Isothermal Amplification (MLAMP) Method, Which Allows Real-time Detection of Multiple Targets in a Single Reaction. This Diagnostic Test Will Be Designed to Differentiate Between Common Subtypes of Ampv (a, B, and C) in a Single Reaction. This Assay Will Be Performed on a Isothermal Instrument, and the Results Will Be Displayed on the Screen as Positive, Negative, or Non-conclusive.assay Performance Will Be Compared With That of the Reference Method (real Time Rt-qpcr). a Simple and Rapid Sample Preparation Method Will Also Be Developed. the Analytical Performance of the Ampv Mlamp Assay Will Be Evaluated by Testing a Cohort Ofpositive (ampv A/b/c) Andnegative Samples.
Committed
$174,395
Paid out
$133.5K
77%
Committed, not yet paid
$40.9K
23%
Everything here is this single award's whole record — signed, amended, paid — not a fiscal-year slice. The by-year charts elsewhere split an award across the years it was committed; this page keeps it whole.
Committed is what the government has legally promised on this award so far. Contracts can also carry a ceiling — the maximum if every option is exercised. Unspent ceiling is headroom, not money owed.
The cash actually disbursed against this award. The gap from committed is the disbursement pipeline: promised, not yet cashed.
Each transaction is a signing event — an action that created or changed the award, dated the day it was signed — not a payment. Negative amounts are real: money de-committed at closeout or renegotiation.
One bar, the award’s whole arithmetic: paid out, then committed, not yet paid, then .
Loading…